Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

vifor fresenius medical care renal pharma ltd. - avacopanum - capsule rigide - avacopanum 10 mg, macrogolglyceroli hydroxystearas 245 mg, macrogolum 4000, kapselhülle: e 172 (rubrum), e 172 (flavum), e 171, gelatina, polysorbatum 80, drucktinte: e 172 (nigrum), pro capsula. - behandlung erwachsener patienten mit schwerer aktiver vaskulitis (granulomatose mit polyangiitis (gpa) oder mikroskopischer polyangiitis (mpa)) - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

stemline therapeutics b.v. - elacestrant - neoplasie al seno - terapia endocrina - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

italfarmaco s.p.a. - itraconazolo - itraconazolo

Unione Europea - italiano - EMA (European Medicines Agency)

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirali per uso sistemico - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

orpha-devel handels und vertriebs gmbh - vasopressina - vasopressina

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

seagen international gmbh - tucatinibum - compresse rivestite con film - tucatinibum 50 mg, copovidonum, crospovidonum, natrii chloridum, kalii chloridum, natrii hydrogenocarbonas, silica colloidalis anhydrica, cellulosum microcristallinum, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 4000, talcum, e 172 (flavum), pro compresso obducto corresp. natrium 9.21 mg, kalium 10.10 mg. - zur behandlung von metastasiertem her2-positivem brustkrebs - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

seagen international gmbh - tucatinibum - compresse rivestite con film - tucatinibum 150 mg, copovidonum, crospovidonum, natrii chloridum, kalii chloridum, natrii hydrogenocarbonas, silica colloidalis anhydrica, cellulosum microcristallinum, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 4000, talcum, e 172 (flavum), pro compresso obducto corresp. natrium 27.65 mg, kalium 30.29 mg. - zur behandlung von metastasiertem her2-positivem brustkrebs - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - levodopum, carbidopum, entacaponum - gel intestinale applicazione - levodopum 20.0 mg, carbidopum monohydricum 5.0 mg corresp. carbidopum 4.6 mg, entacaponum 20.0 mg, carmellosum natricum, natrii hydroxidum, acidum hydrochloridum, aqua purificata, ad gelatum pro 1 ml corresp. natrium 1.95 - 3.24 mg. - behandlung der fortgeschrittenen parkinson-krankheit - synthetika

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

sandoz spa - levodopa/carbidopa - compresse - "100/25mg" 50 compresse a rilascio prolungato in blister al/al

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

sandoz spa - levodopa/carbidopa - compresse - "200/50mg" 30 compresse a rilascio prolungato in blister al/al